Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Global ringworm treatment industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Drug class trends
2.1.4 Route of administration trends
2.1.5 Type trends
2.1.6 Age group trends
2.1.7 Distribution channel trends
Chapter 3 Ringworm Treatment Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of ringworm infections
3.2.1.2 Easy availability of over-the-counter antifungal medications
3.2.1.3 Increased awareness about ringworm infections and its symptoms
3.2.2 Industry pitfalls & challenges
3.2.2.1 Increasing drug resistance to common antifungal medications
3.2.2.2 Lack of patient compliance to treatment
3.3 Growth potential analysis
3.3.1 By drug class
3.3.2 By route of administration
3.3.3 By type
3.3.4 Bt age group
3.3.5 By distributuion channel
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Company positioning matrix
4.5 Strategy dashboard, 2022
Chapter 5 Ringworm Treatment Market Size and Forecast, By Drug Class (USD Million)
5.1 Key trends, by drug class
5.2 Antifungals
5.3 Combination drugs
Chapter 6 Ringworm Treatment Market Size and Forecast, By Route of Administration (USD Million)
6.1 Key trends, by route of administration
6.2 Topical
6.3 Oral
6.4 Parenteral
Chapter 7 Ringworm Treatment Market Size and Forecast, By Type (USD Million)
7.1 Key trends, by type
7.2 Tinea corporis
7.3 Tinea pedis
7.4 Tinea cruris
7.5 Tinea capitis
7.6 Tinea manuum
7.7 Other types
Chapter 8 Ringworm Treatment Market Size and Forecast, By Age Group (USD Million)
8.1 Key trends, by age group
8.2 Below 18 years
8.3 18 - 35 years
8.4 35 - 50 years
8.5 50 years and above
Chapter 9 Ringworm Treatment Market Size and Forecast, By Distribution Channel (USD Million)
9.1 Key trends, by distribution channel
9.2 Hospital pharmacies
9.3 Retail pharmacies
9.4 Online pharmacies
Chapter 10 Ringworm Treatment Market Size and Forecast, By Region (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 MEA
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of MEA
Chapter 11 Company Profiles
11.1 Perrigo Company plc
11.2 Novartis AG
11.3 GlaxoSmithKline Plc
11.4 Teva Pharmaceutical Industries Ltd.
11.5 GLENMARK PHARMACEUTICALS LTD.
11.6 Pfizer Inc.
11.7 Sanofi S.A.
11.8 Merck & Co., Inc.
11.9 Bayer AG
11.10 Gilead Sciences, Inc.
11.11 Eli Lilly and Company
11.12 AbbVie Inc.
